A very serious problem today and sounds like worse tomorrow.
For those not accessing NYT, here is the crux of the problem.
“The problem is straightforward: The companies that have invested billions to develop the drugs have not found a way to make money selling them. Most antibiotics are prescribed for just days or weeks — unlike medicines for chronic conditions like diabetes or rheumatoid arthritis that have been blockbusters — and many hospitals have been unwilling to pay high prices for the new therapies. Political gridlock in Congress has thwarted legislative efforts to address the problem.”
Investors determine the best drugs for great ROI. Short term, but deadly infections are not moneymakers.
Oh well. Don’t cut yourself.